News

Target Stocks Shine as Cramer Highlights Buying Opportunities

Target Stocks Shine as Cramer Highlights Buying Opportunities

Investment Insights from Jim Cramer

On a recent episode of CNBC's “Mad Money Lightning Round,” financial expert Jim Cramer expressed his enthusiasm for Target Corporation (TGT). Cramer mentioned, “I'm going to buy some Target at this price and then wait another five points and buy more.” This straightforward assessment highlights Cramer's confidence in Target's potential performance.

Leadership Changes at Target

Recently, Target selected Jim Lee, a seasoned professional from PepsiCo, Inc (PEP), as its new CFO, effective shortly after the announcement. Lee has accumulated over 25 years of experience in finance and strategy, marking a significant transition for the company. He will be replacing Michael Fiddelke, the previous COO. Lee's history with numerous boards, including Tropicana Brands Group and Celsius Holdings, adds to his credentials.

Unity Software's Financial Performance

Cramer also discussed Unity Software Inc (U), urging listeners to keep an eye on the company's profitability. His perspective is particularly interesting as Macquarie analyst Tim Nollen recently affirmed an Underperform rating for Unity while adjusting its price target upwards from $12 to $15. Cramer remarked, “I think at these levels you want to buy the stock of Merck (MRK),” indicating his belief in Merck's potential amidst market fluctuations.

Merck's Promising Developments

On the healthcare front, Merck recently announced successful results from the Phase 3 KEYNOTE-689 trial for its cancer treatment Keytruda (pembrolizumab). This treatment, designed for patients with newly diagnosed, locally advanced head and neck squamous cell carcinoma, met its primary endpoint of event-free survival. This could position Merck favorably in the competitive pharmaceutical landscape.

Speculation Surrounding Alumis

Additionally, Cramer provided a cautious outlook on Alumis Inc. (ALMS), referring to it as a highly speculative investment. He stated, “That is a really, incredibly speculative situation. As long as you know it's speculative, and you could lose everything on that one, go ahead.” Such insights allow investors to gauge the associated risks of their investments.

Concerns About SoundHound AI

In a contrasting viewpoint, Cramer did not shy away from his criticism of SoundHound AI, Inc. (SOUN), categorizing it as a “meme stock” that struggles with profitability. His analysis follows a recent report from DA Davidson, which maintained a Buy rating on SoundHound with a $9.50 price target. This dichotomy illustrates the varying dynamics in stock performance and investor sentiment.

Recent Stock Movements

The stock market can be volatile and unpredictable. Recent performance data shows that Unity Software shares dipped 0.1% to settle at $21.19. Meanwhile, Alumis shares fell 0.3% to close at $10.32. In contrast, Target shares rose by 1.6%, closing at $151.32, while SoundHound experienced a 1.3% decline, settling at $4.68 during the latest trading session. Merck also saw a slight decrease, closing at $108.52.

Frequently Asked Questions

What stocks did Jim Cramer recommend recently?

Jim Cramer highlighted Target Corporation, Merck, and suggested caution regarding SoundHound AI and Alumis Inc.

Who is the new CFO of Target Corporation?

Jim Lee from PepsiCo has been appointed as the new CFO of Target, bringing over 25 years of experience in finance.

What was the recent performance of Merck's Keytruda?

Merck's Keytruda met its primary endpoint in a Phase 3 trial for treating head and neck cancer, indicating promising results.

How did Target Corporation's stock perform recently?

Target Corporation's stock gained 1.6%, closing at $151.32 in the latest trading session.

What is Jim Cramer’s opinion of SoundHound AI?

Cramer described SoundHound AI as a 'meme stock' that is currently not making money, indicating skepticism towards its investment potential.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Monetary Metals' Bold $38M Gold Bond: A Strategic Leap

Updated Category News Views 20

A Golden Opportunity in Uncertain Times Monetary Metals just pulled a rabbit outta the hat with this $38 million gold bond. That’s tripling the size from their 2024 offering. Normally, I'm skeptical about flashy bond numbers, but there's a glint of genius here. In a world teetering on the brink of financial chaos, investors are itching for something solid. And gold?...

Continue Reading
Ericsson Executes Aggressive $54M Share Buyback

Updated Category News Views 62

Digging Into Ericsson's Latest Buyback Getting straight to brass tacks, the recent maneuver by Ericsson (SE0000108656)—snapping back 500,000 shares from October 26 to October 30, 2026—raised more than a few eyebrows in the financial alleys. Shelling out SEK 54.46 million in less than a week is no small potatoes, but it’s all part of a grander financial ballet...

Continue Reading
ABVC BioPharma Raises $3.39M in Private Placement

Updated Category News Views 0

Dollar Signs and Big Plans: ABVC's Private Placement ABVC BioPharma just bagged $3.39 million through a private placement of senior convertible promissory notes. This ain’t your average financing move, folks. We’re talking original issue discount notes at a hefty 17.5%, maturing by June 2027. This deal takes the cake for today's big plays. Why This Matters to...

Continue Reading
Julie Boland's Strategic Move to Deere's Board

Updated Category News Views 13

Deere & Company Expands Leadership with Boland Out of the blue, Deer & Company (NYSE: DE) decided to shake things up by adding Julie Boland, the former U.S. honcho at Ernst & Young LLP, to their board. Now, when Deere gets a leader with her pedigree, there’s more than a whiff of strategy at play. Let’s unpack why Deere's pulling the trigger on this boardroom shift....

Continue Reading
Good Springs Earns Spot on Inc.'s 2026 Founder List

Updated Category News Views 5

There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....

Continue Reading
IntelliGenome Partners with NL Diagnóstica for TB Battle

Updated Category News Views 30

Breaking New Ground in Tuberculosis Detection When IntelliGenome, a Houston-based developer of CRISPR-based diagnostic tech, teams up with São Paulo's veteran player NL Diagnóstica, you know they're onto something game-changing. This partnership is all about taking the fight against tuberculosis in Brazil to new heights with their CRISPR-Dx™ diagnostic platform. Not...

Continue Reading
Skanska's Bold CZK 2.2B Prague Venture: What's Brewing?

Updated Category News Views 40

Skanska Rolls the Dice with CZK 2.2 Billion We got Skanska pushing forward with a beefy CZK 2.2 billion investment, translating to about SEK 1 billion, into a new residential phase right in the heart of Prague. It's part of the grand Emil Kolben District project, tasked with blending modern living with low-energy savvy in a city that's slowly shrugging off its industrial...

Continue Reading
Young Talent Tackles IVF & Air Pollution Research

Updated Category News Views 24

Rookie Researcher: Jeffrey's Bold Leap at ASRM 2026 Teenagers typically have their heads buried in textbooks, but Jeffrey Huang's got his eyes set on something bigger. This high school junior from Taipei American School leaped onto the international stage at the American Society for Reproductive Medicine (ASRM) 2026, carrying a scientific study centred on a critical...

Continue Reading
HARIBO Unveils Five Boldly Colored Gummies

Updated Category News Views 0

HARIBO's New Fruity Lineup: A Sweet Adventure Hey folks, grab a bag of these new HARIBO gummies, and you're in for a fruity ride. The candy maker's got a new trick up its sleeve with five whimsical, boldly colored gummies. They've dubbed these little treats single-flavor goodies—each with one distinct shape and taste. It's a marketing move that screams 'collect them...

Continue Reading
Abbott's SonicForce Impresses in Crucial Clinical Trial

Updated Category News Views 285

Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...

Continue Reading

Top 5 Most Recently Viewed Articles

Byrna Technologies Earnings Preview: What Investors Need to Know

Updated Category News Views 143

Byrna Technologies Earnings Preview Byrna Technologies (NASDAQ: BYRN) is preparing to deliver its quarterly earnings report, and anticipation is building among investors regarding its performance. To fully understand what to expect, let’s delve into several key points surrounding this earnings announcement. Analyst Earnings Expectations Analysts are predicting that...

Continue Reading
LifeVantage Celebrates Acquisition of LoveBiome for Growth

Updated Category News Views 319

LifeVantage Announces Acquisition of LoveBiome LifeVantage Corporation, a recognized health and wellness entity, recently completed the acquisition of LoveBiome, an innovative direct sales company specialized in comprehensive microbiome care. This significant move marks a pivotal step for LifeVantage, known for its commitment to enhancing cellular health with products...

Continue Reading
Nabsys Earns ISO 9001:2015 Certification, Elevating Quality Standards

Updated Category News Views 149

Nabsys Achieves ISO 9001:2015 Certification Nabsys 2.0, LLC, known for its advancements in electronic genome mapping technology, has successfully earned ISO 9001:2015 certification. This prestigious certification exemplifies Nabsys' dedication to quality management and their commitment to delivering top-notch products and services. Quality Management and Customer Focus...

Continue Reading
High-Performance Computing Market Growth to USD 92.33 Billion

Updated Category News Views 142

High-Performance Computing Market Size Analysis The High-Performance Computing (HPC) market is poised for remarkable growth, with projections indicating an increase from USD 47.07 billion in 2023 to USD 92.33 billion by 2032. This expansion is fueled by a compound annual growth rate (CAGR) of 7.80% from 2024 to 2032. Market Analysis and Demand Drivers High-performance...

Continue Reading
Metagenomi's Groundbreaking Presentations at Scientific Events

Updated Category News Views 140

Metagenomi's Upcoming Presentations at Leading Scientific Conferences Metagenomi, Inc. (Nasdaq: MGX), a pioneering force in precision genetic medicine, is set to share its innovative approaches and advancements in the field through multiple presentations at highly regarded scientific conferences. The company is dedicated to developing curative therapeutics utilizing its...

Continue Reading